chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna COVID-19 Vaccine EUA 2nd dose 4hrs post vaccination injection site pain began 12 hrs post injection fever, chills, muscle pain.  18hrs post severe joint pain, chills and muscle aches. Severe arm pain. Was unable to work or care for my family. Severe fatigue. I slept almost all day.  I took Advil today at 8pm and that relieved my joint pain.
From the time of the PREVNAR IMZ on 9/4/18, it was an estimated 5 days to the approximately 8 inches of redness surrounding the vaccination site. Patient went to an urgent care on 9/8/18  and the doctor diagnosed him with cellulitis resulting from the IMZ of PREVNAR 13. The doctor prescribed a 7 day course of cephalexin twice a day. Outcome is unknown at this time.
a patient showed negative titers on 06/28/2019 for measles, mumps, and rubella after receiving a dose ofMMR II on 03/18/2014, and then a second dose of MMR II on 06/27/2016; a patient showed negative titers on 06/28/2019 for measles, mumps, and rubella after receiving a dose of MMR II on 03/18/2014, and then a second dose of MMR II on 06/27/2016; a patient showed negative titers on 06/28/2019 for measles, mumps, and rubella after receiving a dose of MMR II on 03/18/2014, and then a second dose of MMR II on 06/27/2016; Route of Administration: "IM injection"; This spontaneous report was received from a nurse and refers to a 52-year-old male patient. No information regarding the patient's concomitant medications was provided. He had no pertinent medical history or drug reactions and allergies.  On 18-MAR-2014, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II) intramuscularly, lot # J006136 and expiration date: 24-APR-2015 (dose and frequency were not reported) for prophylaxis. On 27-JUN-2016, the patient was vaccinated with the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II) intramuscularly, lot # L001336 and expiration date: 13-JAN-2017 (dose and frequency were not reported) for prophylaxis. On 28-JUN-2019, the patient showed negative titers for measles, mumps, and rubella in antibody IgG tests. The patient sought medical attention and had unspecified "regular check-up", but did not receive any treatment for the events. The outcome of the events was reported as recovered on an unknown date in 2019. The causality assessment was not provided.
Body aches; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches) and HEADACHE (Headaches) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Body aches) and HEADACHE (Headaches). At the time of the report, PAIN (Body aches) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications taken by the patient were not provided. Treatment activities for event was unknown.
Itchy rash that came on that day of vaccination and has become worse. Treated with Topical Betamethasone.
7/26/10, PM - Headache, dizziness, Faint rash that quickly faded. 7/27/10, AM - Cont Headache, Rash to Abd, and Low grade Fever  7/27/10 4pm Ibuprofen for fever of 103F 7/27/10 430pm Benadryl for Rash/reaction.
Chills; nausea; severe vomiting; diarrhea; chest pain; shortness of breath; tingling on fingers; headache; fever; This is a spontaneous report from a non-contactable nurse (patient). A 50-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: ER8732) via an unspecified route of administration, administered on the right arm on 26Mar2021 12:45 as dose 2, single for COVID-19 immunisation. The patient's medical history was not reported. No known allergies. Concomitant medications included cetirizine hydrochloride (ZYRTEC), fish oil (OMEGA 3 FORTE [FISH OIL]) and birth control pill. The patient previously received first dose of BNT162B2 on 07Mar2021 for COVID-19 immunisation (at 09:00 PM, Lot number: ER8732). On 26Mar2021 22:00, the patient experienced chills, nausea, severe vomiting, diarrhea, chest pain, shortness of breath, tingling on fingers, headache, fever. The events resulted in Emergency room/department or urgent care visit. Therapeutic measures were taken as a result of the events which included IV fluids, EKG (unknown result), chest X-ray (unknown result) and nausea medicine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information available a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events . The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
Painful burning rash with blisters and ulcers, right lower leg.  Diagnosed as herpes zoster acute attack.  Treament: valacyclovir 1000 mg daily x 7 days.
Shortness of breath, body ache, headache, sore scratchy throat, chest pains, vomiting and nausea
heavy voice; sore throat; fever; fatigue; Extra dose administered; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (heavy voice), OROPHARYNGEAL PAIN (sore throat), EXTRA DOSE ADMINISTERED (Extra dose administered), PYREXIA (fever) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066D21A) for COVID-19 vaccination.     Concomitant products included EFINACONAZOLE (JUBLIA), ATORVASTATIN, GLIPIZIDE, METFORMIN, DOLUTEGRAVIR SODIUM (TIVICAY), FEBUXOSTAT and LORAZEPAM for an unknown indication.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Aug-2021, the patient experienced EXTRA DOSE ADMINISTERED (Extra dose administered). On 16-Aug-2021, the patient experienced DYSPHONIA (heavy voice), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever) and FATIGUE (fatigue). At the time of the report, DYSPHONIA (heavy voice), OROPHARYNGEAL PAIN (sore throat), EXTRA DOSE ADMINISTERED (Extra dose administered), PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown.            Treatment information was also not reported.
Shivers, foggy head, head ache, sore arm, tiredness, quizziness! For 5 days after!
pt recv vax 27JUN95 & 24MAR97 or 25MAR97 pt devel a rash consisting of approx 40 to 50 lesions;by 28MAR97 or 29MAR97 pt recovered;
arm soreness and swelling; arm soreness and swelling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 12 year-old female patient received bnt162b2 (BNT162B2), administration date 04Oct2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "headache" (unspecified if ongoing), notes: Her 12 year old daughter is small. She had headaches that predated the vaccination. The patient's concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious), PAIN IN EXTREMITY (non-serious) all with onset Oct2021, outcome "unknown" and all described as "arm soreness and swelling".  Additional information: Description of complaint: It was reported that, she has four children and they all are vaccinated. The other 3 are fine. Her 12 year old daughter was small. She had headaches that predated the vaccination. They were enough to ask the pediatrician about the, but they were not disabling. She received her first vaccine 04Oct2021. She had arm soreness and swelling. Caller had picked her daughter up from school three days in September and had to pick her up three days in October. She got her second vaccine 04Nov2021 and has not been back to school since. The headaches are increasing in intensity and frequency. She has seen peds neurology. Caller's oldest daughter works for Pfizer and caller's husband is a doctor and worked at #. The pediatric neurologist put patient on Beta Blockers and it doesn't help. It doesn't respond to anything. She was not sure if it was related but after the second vaccine they have gotten so severe. They are increasing in severity and not going down. She was a child prior to this and a year ago she had never been sick. She had never been on an antibiotic. She will be getting an MRI and going to headache clinic.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Was given 1st GARDASIL. 5 min later fainted. Hit (L) lateral forehead. Contusion was cleaned & triple antibiotic ointment applies. B/P taken 100/70 L arm.
I had my first vaccine 5 days ago and still have a fever; This case was reported by a consumer via(Shingrix GSK Chatbot) interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd May 2021, the patient received the 1st dose of Shingrix. In May 2021, less than a week after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was not recovered/not resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication. The patient received dose of Shingrix 5 days ago and still experienced fever. The reporter wanted to know was that normal.
pT RECVD VAX ON 5nov92 & W/IN A few hrs, pt exp flu-like sx, body aches, h/a, nausea; No further details were provided;
Patient complained of left upper arm/shoulder pain and stiffness last night after shot was administered.  Redness, swelling to the left upper arm above elbow.  TYLENOL taken with relief of pain.  Patient in our clinic today for assessment.  Seen by doctor mentioned.  Diagnose: Cellulitis, KEFLEX treated.
When I woke up the next morning the entire left side of my face is in pain. Only the side of my face on the same side as my injection site. I feels a little lazy and sore
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2), on 16Dec2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 50 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "IBS" (unspecified if ongoing); "Enlarged Prostrate" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Addition information: Other medication in 2 weeks was none. Known allergies was none. Vaccine received was yes. Treatment start date was 16May2022 and treatment stop date was 20May2022. Got rebound COVID after antiviral on 26May2022 and no treatment was received for it and recovering.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recvd 3 doses of Engerix-B in 89-90 & exp low temp, sore arm & was very sick to stomach; 12NOV92 still nauseous; pt adm to hosp 15NOV92 w/stomach pain, pain in upper rt quad, no appetite, sour taste in mouth;
Statement per email from patient: I had my flu shot in October and golfed the next day.  Within these 2 days the arm that I received my immunization in became very sore and began to stiffen up.  The long and short of it, I soon lost my range of motion and now am seeing my physical therapist to regain that motion.  PT said it is a "a traumatized muscle".
Initial and follow-up information has been received from an RN concerning a 55 year old white female pt who was vaccinated with a 2nd dose of pnemococcal vaccine 23 polyvalent and the 1st dose of influenza virus vaccine. It was noted that the 2 vaccines were administered in the same arm. On 10/5/99, the pt experienced injection site redness, tenderness, and hardness. In addition, the injection site was swollen. The pt also complained of shortness of breath although "lungs clear to auscultation" with dry mouth. She was seen by a physician the next day, because her physician expressed concern that she might experience abscess in the arm. She was also scheduled to see a physician for re-evaluation. Subsequently, the pt recovered from all her experiences. No further details are expected.
Pt had v. good dr. appt; had flu shot and stopped for lunch and was very sick before food was delivered. Taken by ambulance to hospital. All within 2 hrs from shot; BP dropped - dry heaves, v. weak.  12/17/2007 MR received for DOS 10/3-6/2007 with D/C Dx:  Syncope and Collapse.  Principal DX: Pre-syncope. UTI. 2' DX: Dehydration.  Pt transported to ER after episode of nausea, vomiting, diaphoresis and light-headedness while eating after flu shot receipt.  Pt reports recent diarrhea with blood. Pt dropped BP on sitting and standing.  Orthostasis resolved with IVF. UTI txd with abx. Pt d/cd to skilled care facility.
I am still in a lot of pain. It doesn't happen every day, but some days the pain is so bad, I can only lift my arm half way; I am still in a lot of pain. It doesn't happen every day, but some days the pain is so bad, I can only lift my arm half way; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 25 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), JOINT RANGE OF MOTION DECREASED (non-serious), outcome "unknown" and all described as "I am still in a lot of pain. It doesn't happen every day, but some days the pain is so bad, I can only lift my arm half way".  Additional Information: Reporter stated that she received the 1st dose about a month ago. "I am still in a lot of pain. It doesn't happen every day, but some days the pain is so bad, I can only lift my arm half way. I was getting ready to get the vaccine . I am not sure how to proceed, if I should delay or just go through with it. I am supposed  to get the vaccine today. I had a side effect after the first dose of the vaccine.  Should I get the second dose? PQC Present was reported as No.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Narrative:  BEGAN SAME DAY AS INJECTION AND LASTED 1-2 DAYS. CURRENTLY ALL SIDE EFFECTS RESOLVED
This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart is pounding fast but off and on), VACCINATION COMPLICATION (She had something different on Thanksgiving Day), HEART RATE INCREASED (Every day this week heart rate is higher) and ANXIETY (Very concerned) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination. Previously administered products included for COVID-19 vaccination: Johnson & Johnson COVID-19 Vaccine (lot 042A21A) on 10-Apr-2021. Past adverse reactions to the above products included No adverse event with Johnson & Johnson COVID19 Vaccine. On 24-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced PALPITATIONS (Heart is pounding fast but off and on). On 25-Nov-2021, the patient experienced VACCINATION COMPLICATION (She had something different on Thanksgiving Day). In January 2022, the patient experienced HEART RATE INCREASED (Every day this week heart rate is higher) and ANXIETY (Very concerned). At the time of the report, PALPITATIONS (Heart is pounding fast but off and on) had not resolved and VACCINATION COMPLICATION (She had something different on Thanksgiving Day), HEART RATE INCREASED (Every day this week heart rate is higher) and ANXIETY (Very concerned) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jan-2022, Heart rate: 131 heart rate was 131. On 22-Jan-2022, Heart rate: 131 heart rate was 131. In 2022, Heart rate: high (High) Every day this week its higher. On an unknown date, Electrocardiogram: normal (normal) everything was fine. On an unknown date, Heart rate: 115 heart rate was 115. She had no side effects from the J and J. Her heart was pounding fast but off and on. She thought it should go away for a day or so, it was still there, 8 weeks later. The patient states this was from Moderna 100 percentage because she had an EKG earlier in the year. No concomitant products were reported. No treatment drugs were reported.
Like flu symptoms; Muscle pains; Fever; General tiredness; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (Like flu symptoms), MYALGIA (Muscle pains), PYREXIA (Fever) and FATIGUE (General tiredness) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Like flu symptoms), MYALGIA (Muscle pains), PYREXIA (Fever) and FATIGUE (General tiredness). At the time of the report, INFLUENZA LIKE ILLNESS (Like flu symptoms), MYALGIA (Muscle pains), PYREXIA (Fever) and FATIGUE (General tiredness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment medications were unknown.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events are not applicable.
This spontaneous report as received from an unspecified provider at a conference via a company representative, refers to a 68 year old patient of unknown gender. No pertinent medical history or drug reactions/allergies were provided. The reporter stated that on an unknown date the patient was administered ZOSTAVAX (dose, route and lot number not provided), and experienced three shingles outbreaks in the hip area (dates unspecified). At the time of the report, the outcome of the event was unkown. Additional information is not expected because the reporter details were not provided.
inconsolable crying 4-6 hrs; APAP, Pediaprophen given;
Pt received single dose Flu vaccine in (L) deltoid on 11/11/15. Next day school nse notes arm red, hot; swollen and painful. Eval in office -> 9x13 cm red, warm, indurated (L) deltoid, able to lift arm 45 degrees but unable to lift to shoulder level. 11/15/15 redness resolved, still sl warm and swollen.
30 patients received Monovalent Moderna Vaccine past the manufacturers expiration date; no adverse event; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (30 patients received Monovalent Moderna Vaccine past the manufacturers expiration date) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (30 patients received Monovalent Moderna Vaccine past the manufacturers expiration date) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (30 patients received Monovalent Moderna Vaccine past the manufacturers expiration date) and NO ADVERSE EVENT (no adverse event) outcome was unknown.            No concomitant drug information was provided.  It was reported that there were 3 lot numbers. Lot 022D21A with expiration 20Apr2022, Lot 033F21A with expiration 08Apr2022 and Lot 037C21A with expiration 2Jan2022.  In total 30 doses were administered with 13, 11, and 6 different doses from different lot numbers.      No treatment medication information was provided.  The case was reported for 3rd out  of 30 adult patients who had received the vaccine as reported by the reporter.
Immediately after Moderna vaccination patient presented with localized urticaria. LPN gave 50 mg Diphenhydramine IM at appx 1410. felt relief and urticaria resolved almost completely.  complained of feeling off from the diphenhydramine.  She admitted she had barely ate today and was anxious.  Water, crackers and sucker given.  She then complained of throat irritation ,potential throat swelling and overall feeling off.  0.5 ml epinephrine given by RN. and 911 was called by RN.  Epinephrine was given at 1418 and ambulance was on site withing 3 minutes.  Patient was talking, able to stand with assistance and did not want to lay down or position with feet up.  Patient was alert and orientated. She was taken to hospital by ambulance.
2 days status post injection, erythema and ecchymosis noted in nearly band like distribution distal to the vaccination site.
Patient had no issue with the first dose of vaccine. He is experiencing shingle like rashes on his leg and fore arm. The rashes have blisters and are drying up. No pain, itchiness or fever noted.